Haemophilia B Leyden: Factor IX Promoter Mutations, Post-Pubertal Recovery and the Androgen Receptor, with MCQs

Haematology ยท Coagulation disorders

A factor IX deficiency that gets better at puberty: where the mutation sits, why androgens rescue it, the one variant that never recovers, and the DM Hematopathology entrance question it inspired.

PMPathology MCQ Editorial TeamUpdated Oct 20265 min read
Haemophilia B Leyden cover: blood cell field labelled factor IX below 1% in childhood and rising factor IX after puberty, Pathology MCQ.
At a glance
  • What it is: a rare X-linked form of haemophilia B caused by mutations in the factor IX (F9) gene promoter
  • Childhood: factor IX activity from below 1% to about 13%, with typical haemophilia bleeding
  • After puberty: factor IX rises to about 50โ€“70% and bleeding largely stops
  • Why: androgens act through an androgen-responsive element in the promoter to restore transcription
  • Exception: haemophilia B Brandenburg (mutation at position โˆ’26) disrupts that element and does not improve

Mechanism

Most haemophilia B mutations alter the factor IX protein. In the Leyden form, the coding sequence is normal; point mutations sit in the promoter, roughly between nucleotides โˆ’20 and +13. They block binding of liver transcription factors such as hepatocyte nuclear factor 4 (HNF4) and C/EBP, so little factor IX is made in childhood.

The promoter also contains an androgen-responsive element (a steroid receptor binding site). As testosterone rises at puberty, the androgen receptor binds this element and drives transcription despite the mutation, so factor IX levels climb towards normal.

Key point

The rescue depends on an intact androgen-responsive element. In haemophilia B Brandenburg the mutation at โˆ’26 sits within that element, so androgens cannot act and the deficiency persists into adult life.

Clinical course

Before and after puberty
ChildhoodAfter puberty
Factor IX activityBelow 1% to about 13%About 50โ€“70% of normal
BleedingHaemarthroses, muscle and post-traumatic bleedingLargely resolves
TreatmentFactor IX replacement as for other haemophilia BOften none; cover for major surgery if levels are low

Laboratory and management

  • Coagulation screen: prolonged APTT with normal PT, corrected by mixing with normal plasma.
  • Factor assay: low factor IX in childhood; repeat after puberty to document recovery.
  • Genetics: F9 sequencing that includes the promoter region identifies the Leyden mutation and predicts improvement, which guides counselling and long-term prophylaxis plans.
  • Carriers: X-linked inheritance; female carriers may have mildly low levels.
Exam focus

The classic stem is a boy with haemophilia B whose bleeding stops after puberty. The answer is a promoter mutation rescued by the androgen (steroid) receptor; anabolic steroids have been used to raise factor IX in some patients.

Practice questions

PRACTICE ยท SBA1 of 3

A boy with severe haemophilia B stops bleeding after puberty, when his factor IX rises to 60%. Which receptor explains the recovery?

Show answer
Correct: C. Androgens bind the androgen receptor, which acts on a responsive element in the F9 promoter and restores transcription.
PRACTICE ยท SBA2 of 3

Where are the mutations in haemophilia B Leyden located?

Show answer
Correct: B. The protein itself is normal; promoter mutations reduce how much is made until androgens restore transcription.
PRACTICE ยท SBA3 of 3

Why does haemophilia B Brandenburg not improve after puberty?

Show answer
Correct: B. The โˆ’26 mutation lies within the androgen-responsive element, so the androgen receptor cannot rescue transcription.
Key takeaways
  • Haemophilia B Leyden is caused by F9 promoter mutations, not coding mutations.
  • Factor IX is very low in childhood and rises to about 50โ€“70% after puberty.
  • Androgens act through an androgen-responsive element in the promoter.
  • The Brandenburg variant (โˆ’26) disrupts that element and does not improve.
References

Crossley M, Ludwig M, Stowell KM, et al. Recovery from hemophilia B Leyden: an androgen-responsive element in the factor IX promoter. Science 1992;257:377โ€“379 ยท Reijnen MJ, Sladek FM, Bertina RM, Reitsma PH. Disruption of a binding site for hepatocyte nuclear factor 4 results in hemophilia B Leyden. Proc Natl Acad Sci USA 1992;89:6300โ€“6303 ยท Hoffbrand AV, Steensma DP. Hoffbrandโ€™s Essential Haematology, 8th ed. Wiley-Blackwell; 2019

PM

Pathology MCQ Editorial TeamWritten and reviewed by practising pathologists who teach FRCPath, NEET-SS, INI-SS and MD/DNB candidates.

Practice bank

High-Yield, Board-Style Image MCQs & Interactive Whole Slide Images

High-resolution virtual microscopy with questions aligned to ABP, FRCPath, NEET-SS, DM Hematopathology and MD/DNB.


Discover more from PATHOLOGY MCQs

Subscribe to get the latest posts sent to your email.

Leave a Reply

You cannot copy content of this page

Discover more from PATHOLOGY MCQs

Subscribe now to keep reading and get access to the full archive.

Continue reading